Daily ShareChat: Fisher & Paykel Healthcare
By Jenny Ruth
Although Fisher & Paykel Healthcare's annual results were in line with expectations, management's "very downbeat" guidance for the year ending March 2010 has led Morningstar to downgrade its forecasts.
With the New Zealand dollar at 60 US cents, the company expects to achieve net profit between $75 million and $80 million. "This is well below our net profit forecast of $104 million," Morningstar says.
In late May, the respiratory humidification and obstructive sleep apnea (OSA) products company reported a 76% rise in annual net profit to $62.2 million.
"We are not too concerned about this year's earnings but are more focused on the health of the business in general which remains in good shape," Morningstar says.
"We are comfortable with the firm's strategy to invest for the future, even if it means sacrificing short-term earnings," it says.
New products launched during the year just gone should help the company regain market share in the OSA market while its respiratory humidification business will continue to deliver strong underlying growth, it says.
"We also look forward to margin uplift from savings in Mexico and expansion into other geographies."
Fisher & Paykel Healthcare is setting up a manufacturing facility in Mexico to raise capacity and free up resources at its Auckland head office.
BROKER CALL: Morningstar rate Fisher & Paykel Healthcare (NZX: FPH ) as HOLD.
Daily ShareChat articles report how the main experts in the market might view a certain share and we provide this commentary as a useful resource for investors. Content on this site does not in any way constitute a recommendation to buy, hold or sell any particular share. Investors should always seek professional advice before making any investment decisions.
Related News
F&P Healthcare commits to third Auckland building as part of $33M spending plan F&P Healthcare humidification products will drive earnings, Morningstar says Daily ShareChat: Fisher & Paykel Healthcare Record profit for Fisher & Paykel Healthcare - outlook strong F&P Healthcare trims $23m of debt F&P Healthcare forecasts 25% gain in 2010 profit on sales growth Daily ShareChat: Fisher & Paykel Healthcare F&P Healthcare stocks drops as profit forecast misses estimates F&P Healthcare posts 76% profit jump on weaker kiwi, respirator sales Daily ShareChat: Fisher & Paykel Healthcare
NZX Annoucements for FPH
|
Fisher & Paykel Healthcare Corporation Limited Ord Shares
Current quote:
FPH $3.27 -3
Quotes delayed 20 minutes
Price when article published: $3.15
Previous News
Sharemarket News By Email
Stock Quote
At a Glance
| NZX 50 Index |
3225.14 |
 |
1.70 |
| S&P/ASX 200 |
4818.10 |
 |
3.90 |
| Dow Jones Industrials |
10624.70 |
 |
12.80 |
Comment & Analysis
|
“
Fund managers bleary from a night celebrating the success of their own kind awoke Thursday morning to news that an outsider, and upstart competitor, had slipped up.
After weeks of controversy the resignation of Peter Huljich from the investment/KiwiSaver company he started was not really surprising.
Few rivals will miss him but the mood amongst [...]
”
David Chaplin More »
|
|
|